Supplement tables and figures for Associations between life-course body shape and sex hormone concentrations in men, pre- and postmenopausal women

Supplemental Table 1. Trajectory modelling and model fit characteristics in men (HPFS), postmenopausal women (NHS+ NHS II) and premenopausal women (NHS+ NHS II).

Supplemental Table 2. Sensitivity analysis on women who have never been exposed to hormone therapy. Percentage difference in biomarker levels between the reference group (the medium-stable group in postmenopausal women and the lean-stable/moderate group in premenopausal women) and the other trajectory groups in postmenopausal (NHS+ NHS II) and premenopausal women (NHS+ NHS II)

Supplement Figure1. Flowchart of study participants. a) Of 3053 eligible men in the HPFS, 2431 were included in the final study. b) Of 7860 eligible women in the NHS study and 4517 in the NHS 2, 4801 premenopausal and 6018 postmenopausal women were included in the final study.

补充表 1：男性（HPFS）、绝经后女性（NHS+ NHS II）和绝经前女性（NHS+ NHS II）的轨迹建模及模型拟合特征。

补充表 2：针对从未接受过激素疗法的女性的敏感性分析。在绝经后女性（NHS+ NHS II）和绝经前女性（NHS+ NHS II）中，参考组（绝经后女性的中等稳定组和绝经前女性的瘦稳定/适度组）与其他轨迹组之间生物标志物水平的百分比差异。

补充图 1：研究参与者的流程图。a) 在 HPFS 研究的 3053 名合格男性中，2431 名被纳入最终研究。b) 在 NHS 研究的 7860 名合格女性和 NHS 2 的 4517 名女性中，4801 名绝经前女性和 6018 名绝经后女性被纳入最终研究。